Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-01-06

Clinical Trial Update: Pharmacokinetics and Tolerability of Rufinamide in Healthy Chinese Subjects [Phase 1]

View source ↗

Summary

Phase 1 study assessing pharmacokinetics and tolerability of Rufinamide in healthy Chinese subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Rufinamide (Rufinamide)

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Seizures | Phase 1 | Status: COMPLETED